Abstract:Candida albicans adapts to various conditions in different body niches by regulating gene expression, protein synthesis, and metabolic pathways. These adaptive reactions not only allow survival but also influence the interaction with host cells, which is governed by the composition and structure of the fungal cell wall. Numerous studies had shown linkages between mitochondrial functionality, cell wall integrity and structure, and pathogenicity. Thus, we decided to inhibit single complexes of the respiratory chain of C. albicans and to analyze the resultant interaction with macrophages via their phagocytic activity. Remarkably, inhibition of the fungal bc1 complex by antimycin A increased phagocytosis, which correlated with an increased accessibility of β-glucans. To contribute to mechanistic insights, we performed metabolic studies, which highlighted significant changes in the abundance of constituents of the plasma membrane. Collectively, our results reinforce the strong linkage between fungal energy metabolism and other components of fungal physiology, which also determine the vulnerability to immune defense reactions.IMPORTANCE The yeast Candida albicans is one of the major fungal human pathogens, for which new therapeutic approaches are required. We aimed at enhancements of the phagocytosis efficacy of macrophages by targeting the cell wall structure of C. albicans, as the coverage of the β-glucan layer by mannans is one of the immune escape mechanisms of the fungus. We unambiguously show that inhibition of the fungal bc1 complex correlates with increased accessibilities of β-glucans and improved phagocytosis efficiency. Metabolic studies proved not only the known direct effects on reactive oxygen species (ROS) production and fermentative pathways but also the clear downregulation of the ergosterol pathway and upregulation of unsaturated fatty acids. The changed composition of the plasma membrane could also influence the interaction with the overlying cell wall. Thus, our work highlights the far-reaching relevance of energy metabolism, indirectly also for host-pathogen interactions, without affecting viability.

The high adaptability and metabolism of Candida albicans

The Species Distribution of Candidemia and the Advances on Diagnosis and Treatment

Inhibition of Respiration of Candida albicans by Small Molecules Increases Phagocytosis Efficacy by Macrophages

Time Course of Global Gene Expression Alterations in Candida Albicans During Infection of Hela Cells

Adaptation to an amoeba host drives selection of virulence-associated traits and genetic variation in saprotrophic Candida albicans

Candida albicans exhibits heterogeneous and adaptive cytoprotective responses to antifungal compounds

Candida albicans pathogenicity mechanisms

Glycogen Metabolism in Candida albicans Impacts Fitness and Virulence during Vulvovaginal and Invasive Candidiasis

The adaptive response to iron involves changes in energetic strategies in the pathogen Candida albicans

Parallel evolution of fluconazole resistance and tolerance in Candida glabrata

Tipping the Balance: C. albicans Adaptation in Polymicrobial Environments

Differential Gene Expression Analysis in Candida albicans: A Comparative Study Between Malic Acid and Glucose Media for Insights into Pathogenicity and Metabolic Pathway Interactions

Evaluation of biofilm formation and antimicrobial susceptibility (drug resistance) of Candida albicans isolates

Adaptation of Candida albicans to specific host environments by gain-of-function mutations in transcription factors

The advances in the regulation of immune microenvironment by Candida albicans and macrophage cross-talk

Immediate and delayed remifentanil-induced hypersensitivity.

Lethal metabolism of Candida albicans respiratory mutants

Insights into Candida Albicans: A New Perspective on Pathogenic Factors and Regulatory Mechanisms

Targeting Virulence Factors of Candida albicans with Natural Products

Metabolomic Profiling for the Identification of Potential Biomarkers Involved in a Laboratory Azole Resistance in Candida Albicans.